Cargando…

Evaluation of circulating leucocyte populations both in subjects with previous SARS-COV-2 infection and in healthy subjects after vaccination

Innate immune mechanisms are central players in response to the binding of pathogens to pattern-recognition receptors providing a crucial initial block on viral replication. Moreover, innate immune response mobilizes cells of the cellular-mediated immune system, which develop into effector cells tha...

Descripción completa

Detalles Bibliográficos
Autores principales: Grimaldi, Vincenzo, Benincasa, Giuditta, Moccia, Giusi, Sansone, Annunziata, Signoriello, Giuseppe, Napoli, Claudio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8802555/
https://www.ncbi.nlm.nih.gov/pubmed/35114198
http://dx.doi.org/10.1016/j.jim.2022.113230
_version_ 1784642706044092416
author Grimaldi, Vincenzo
Benincasa, Giuditta
Moccia, Giusi
Sansone, Annunziata
Signoriello, Giuseppe
Napoli, Claudio
author_facet Grimaldi, Vincenzo
Benincasa, Giuditta
Moccia, Giusi
Sansone, Annunziata
Signoriello, Giuseppe
Napoli, Claudio
author_sort Grimaldi, Vincenzo
collection PubMed
description Innate immune mechanisms are central players in response to the binding of pathogens to pattern-recognition receptors providing a crucial initial block on viral replication. Moreover, innate immune response mobilizes cells of the cellular-mediated immune system, which develop into effector cells that promote viral clearance. Here, we observed circulating leukocyte T cell response in healthy subjects, COVID-19 infected, and in healthy vaccinated subjects. We found a significant CD8(+) T cells (p < 0,05) decrease and an augmented CD4(+)/CD8(+) ratio (p < 0,05) in COVID-19 infected group compared with vaccinated subjects. In addition, healthy vaccinated subjects have a significant increased expression of CD8(+) T cells, and a reduction of CD4(+)/CD8(+) ratio with respect to subjects previously COVID-19 infected. Central Memory and Terminal Effector Memory cells (TEMRA) increased after vaccine but not among groups.
format Online
Article
Text
id pubmed-8802555
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-88025552022-01-31 Evaluation of circulating leucocyte populations both in subjects with previous SARS-COV-2 infection and in healthy subjects after vaccination Grimaldi, Vincenzo Benincasa, Giuditta Moccia, Giusi Sansone, Annunziata Signoriello, Giuseppe Napoli, Claudio J Immunol Methods Technical Note Innate immune mechanisms are central players in response to the binding of pathogens to pattern-recognition receptors providing a crucial initial block on viral replication. Moreover, innate immune response mobilizes cells of the cellular-mediated immune system, which develop into effector cells that promote viral clearance. Here, we observed circulating leukocyte T cell response in healthy subjects, COVID-19 infected, and in healthy vaccinated subjects. We found a significant CD8(+) T cells (p < 0,05) decrease and an augmented CD4(+)/CD8(+) ratio (p < 0,05) in COVID-19 infected group compared with vaccinated subjects. In addition, healthy vaccinated subjects have a significant increased expression of CD8(+) T cells, and a reduction of CD4(+)/CD8(+) ratio with respect to subjects previously COVID-19 infected. Central Memory and Terminal Effector Memory cells (TEMRA) increased after vaccine but not among groups. Elsevier B.V. 2022-03 2022-01-31 /pmc/articles/PMC8802555/ /pubmed/35114198 http://dx.doi.org/10.1016/j.jim.2022.113230 Text en © 2022 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Technical Note
Grimaldi, Vincenzo
Benincasa, Giuditta
Moccia, Giusi
Sansone, Annunziata
Signoriello, Giuseppe
Napoli, Claudio
Evaluation of circulating leucocyte populations both in subjects with previous SARS-COV-2 infection and in healthy subjects after vaccination
title Evaluation of circulating leucocyte populations both in subjects with previous SARS-COV-2 infection and in healthy subjects after vaccination
title_full Evaluation of circulating leucocyte populations both in subjects with previous SARS-COV-2 infection and in healthy subjects after vaccination
title_fullStr Evaluation of circulating leucocyte populations both in subjects with previous SARS-COV-2 infection and in healthy subjects after vaccination
title_full_unstemmed Evaluation of circulating leucocyte populations both in subjects with previous SARS-COV-2 infection and in healthy subjects after vaccination
title_short Evaluation of circulating leucocyte populations both in subjects with previous SARS-COV-2 infection and in healthy subjects after vaccination
title_sort evaluation of circulating leucocyte populations both in subjects with previous sars-cov-2 infection and in healthy subjects after vaccination
topic Technical Note
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8802555/
https://www.ncbi.nlm.nih.gov/pubmed/35114198
http://dx.doi.org/10.1016/j.jim.2022.113230
work_keys_str_mv AT grimaldivincenzo evaluationofcirculatingleucocytepopulationsbothinsubjectswithprevioussarscov2infectionandinhealthysubjectsaftervaccination
AT benincasagiuditta evaluationofcirculatingleucocytepopulationsbothinsubjectswithprevioussarscov2infectionandinhealthysubjectsaftervaccination
AT mocciagiusi evaluationofcirculatingleucocytepopulationsbothinsubjectswithprevioussarscov2infectionandinhealthysubjectsaftervaccination
AT sansoneannunziata evaluationofcirculatingleucocytepopulationsbothinsubjectswithprevioussarscov2infectionandinhealthysubjectsaftervaccination
AT signoriellogiuseppe evaluationofcirculatingleucocytepopulationsbothinsubjectswithprevioussarscov2infectionandinhealthysubjectsaftervaccination
AT napoliclaudio evaluationofcirculatingleucocytepopulationsbothinsubjectswithprevioussarscov2infectionandinhealthysubjectsaftervaccination